查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1741408

止痛贴市场：按类型、按应用、按技术、按剂型、按配方、按患者年龄、按黏合特性、按作用持续时间、按药物类别、按分销管道、按地区

Pain Patch Market, By Type, By Application, By Technology, By Formulation, By Prescription, By Patient Age, By Adhesive Properties, By Duration of Action, By Drug Class, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年止痛贴市场价值估计为 58.3 亿美元，预计到 2032 年将达到 82 亿美元，2025 年至 2032 年的复合年增长率为 5%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 58.3亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期：2025-2032年复合年增长率： 5.00% 2032年价值预测 82亿美元

止痛贴，又称经皮吸收贴片，是一种黏性贴剂，可直接透过皮肤释放药物，缓解局部疼痛。这类贴片使用方便，易于使用，并可在较长时间内控制药物释放。

市场动态：

疼痛贴片市场的成长主要源自于慢性疼痛疾病（如关节炎、下背痛和神经病变疼痛）的日益普及。这些疾病需要长期的疼痛管理方案，而疼痛贴片则提供了一种方便有效的解决方案。此外，人们越来越意识到口服止痛药的潜在风险，例如成瘾和胃肠道副作用，这促使人们更加关注像疼痛贴片这样的非侵入性给药系统。

然而，市场成长仍面临许多阻碍因素。与传统止痛药相比，止痛贴价格昂贵，且部分地区对此类产品的报销有限，这些因素可能会限制市场扩张。此外，止痛贴的核准监管要求严格，且使用止痛贴可能引发皮肤刺激和过敏反应，这些因素也对市场成长构成挑战。

儘管面临诸多挑战，止痛贴市场仍蕴藏着许多成长机会。无线连接和感测器整合等先进技术在止痛贴中的应用日益广泛，为创新和产品差异化铺平了道路。此外，新兴市场尚未开发的潜力以及对个人化疼痛管理解决方案日益增长的需求，为市场参与者扩大影响力、满足多样化消费群体的机会提供了良机。

本研究的主要特点

  • 本报告对全球止痛贴市场进行了详细分析，并给出了预测期（2025-2032）的市场规模和年复合成长率（CAGR%），假设 2024 年为基准年。
  • 它还揭示了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、财务业绩和策略等参数，对全球止痛贴市场中的主要企业进行了概述。
  • 本报告的见解可以帮助负责人和公司经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球止痛贴市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员将透过用于分析全球止痛贴市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

  • 市场动态
    • 对有效缓解疼痛和非侵入性治疗的需求不断增加
    • 皮肤敏感和刺激
    • 个性化疼痛管理的出现
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

第四章 止痛贴市场-冠状病毒（COVID-19）大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 2020 年至 2032 年止痛贴市场（按类型）

  • 阿片类药物
  • 非阿片类药物

6. 2020 年至 2032 年止痛贴市场（按应用）

  • 慢性疼痛
  • 急性疼痛

7. 2020 年至 2032 年止痛贴市场（依技术划分）

  • 常规药物输送贴片
  • 先进的药物传输贴片

8. 2020-2032 年止痛贴市场（以剂型划分）

  • 单一代理
  • 联合治疗

9. 2020 年至 2032 年止痛贴市场（依配方）

  • 处方
  • OTC

第 10 章。 2020 年至 2032 年依病患年龄分類的止痛贴市场

  • 成人
  • 孩子们

第 11 章 2020 年至 2032 年止痛贴市场（依黏合剂特性）

  • 低过敏性
  • 标准

第 12 章。 2020 年至 2032 年止痛贴市场（依作用持续时间划分）

  • 短效
  • 缓释性

第 13 章。 2020 年至 2032 年止痛贴市场（依药物类别划分）

  • 非类固醇抗发炎药贴剂
  • 局部麻醉贴片
  • 其他的

第 14 章。 2020 年至 2032 年按通路分類的止痛贴市场

  • 零售药局
  • 医院和诊所

第 15 章。 2020 年至 2032 年按地区分類的止痛贴市场

  • 北美洲
      • 美国
      • 加拿大
  • 欧洲
      • 德国
      • 英国
      • 法国
      • 义大利
      • 西班牙
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • 澳洲
      • 韩国
      • ASEAN
      • 其他亚太地区
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 中东
      • GCC
      • 以色列
      • 其他中东地区
  • 非洲
      • 南非
      • 中部非洲
      • 北非

第十六章竞争格局

  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis AG
  • Mylan NV
  • Endo Pharmaceuticals
  • Teikoku Pharma USA, Inc.
  • Acorda Therapeutics
  • Ibsa Institut Biochimique SA
  • Alembic Pharmaceuticals
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceuticals
  • Strativa Pharmaceuticals
  • Galen Limited
  • Napp Pharmaceuticals

第 17 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6204

Pain Patch Market is estimated to be valued at USD 5.83 Bn in 2025 and is expected to reach USD 8.2 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 5.83 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.00% 2032 Value Projection: USD 8.2 Bn

Pain patches, also known as transdermal patches, are adhesive patches that deliver medication directly through the skin to provide localized pain relief. These patches are convenient, easy to use, and offer a controlled release of medication over an extended period.

Market Dynamics:

The pain patch market is primarily driven by the increasing prevalence of chronic pain conditions, such as arthritis, back pain, and neuropathic pain. These conditions require long-term pain management solutions, and pain patches offer a convenient and effective option. Moreover, the rising awareness about the potential risks associated with oral pain medications, such as addiction and gastrointestinal side effects, is shifting the focus towards non-invasive drug delivery systems like pain patches.

However, the market growth may be hindered by certain factors. The high cost of pain patches compared to traditional pain medications and the limited availability of reimbursement for these products in some regions may restrict market expansion. Additionally, the stringent regulatory requirements for the approval of pain patches and the risk of skin irritation or allergic reactions associated with patch usage pose challenges to market growth.

Despite these challenges, the pain patch market presents several opportunities for growth. The increasing adoption of advanced technologies, such as wireless connectivity and sensor integration in pain patches, opens up avenues for innovation and product differentiation. Furthermore, the untapped potential of emerging markets and the growing demand for personalized pain management solutions provide opportunities for market players to expand their presence and cater to a diverse consumer base.

Key features of the study:

  • This report provides in-depth analysis of the global pain patch market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pain patch market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Pfizer Inc., Novartis AG, Mylan N.V., Endo Pharmaceuticals, Teikoku Pharma USA, Inc., Acorda Therapeutics, Ibsa Institut Biochimique SA, Alembic Pharmaceuticals, Noven Pharmaceuticals, Inc., Teva Pharmaceuticals, Strativa Pharmaceuticals, Galen Limited, and Napp Pharmaceuticals
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pain patch market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pain patch market

Detailed Segmentation:

  • Global Pain Patch Market, By Type
    • Opioid Pain Patches
    • Non-Opioid Pain Patches
  • Global Pain Patch Market, By Application
    • Chronic Pain Patches
    • Acute Pain Patches
  • Global Pain Patch Market, By Technology
    • Traditional Drug Delivery Patches
    • Advanced Drug Delivery Patches
  • Global Pain Patch Market, By Formulation
    • Single Medication Patches
    • Combination Therapy Patches
  • Global Pain Patch Market, By Prescription
    • Prescription Pain Patches
    • Over-the-Counter (OTC) Pain Patches
  • Global Pain Patch Market, By Patient Age
    • Adult Pain Patches
    • Pediatric Pain Patches
  • Global Pain Patch Market, By Adhesive Properties
    • Hypoallergenic Patches
    • Standard Adhesive Patches
  • Global Pain Patch Market, By Duration of Action
    • Short-Acting Patches
    • Extended-Release Patches
  • Global Pain Patch Market, By Drug Class
    • NSAID Patches
    • Local Anesthetic Patches
    • Other Medication Patches
  • Global Pain Patch Market, By Distribution Channel
    • Retail Pharmacies
    • Hospitals and Clinics
  • Global Pain Patch Market, By Geography
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles
    • Hisamitsu Pharmaceutical Co., Inc.
    • Johnson & Johnson
    • Pfizer Inc.
    • Novartis AG
    • Mylan N.V.
    • Endo Pharmaceuticals
    • Teikoku Pharma USA, Inc.
    • Acorda Therapeutics
    • Ibsa Institut Biochimique SA
    • Alembic Pharmaceuticals
    • Noven Pharmaceuticals, Inc.
    • Teva Pharmaceuticals
    • Strativa Pharmaceuticals
    • Galen Limited
    • Napp Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet , By Type
    • Market Snippet , By Application
    • Market Snippet , By Technology
    • Market Snippet , By Formulation
    • Market Snippet , By Prescription
    • Market Snippet , By Patient Age
    • Market Snippet , By Adhesive Properties
    • Market Snippet , By Duration of Action
    • Market Snippet , By Drug Class
    • Market Snippet , By Distribution Channel
    • Market Snippet , By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing demand for effective pain relief and non-invasive treatment
    • Skin Sensitivity and Irritation
    • Emergence of Personalized Pain Management
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Pain Patch Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Pain Patch Market, By Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Opioid Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Non-Opioid Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Pain Patch Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Chronic Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Acute Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Pain Patch Market, By Technology, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Traditional Drug Delivery Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Advanced Drug Delivery Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Pain Patch Market, By Formulation, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Single Medication Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Combination Therapy Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Pain Patch Market, By Prescription, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Prescription Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Over-the-Counter (OTC) Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

10. Pain Patch Market, By Patient Age, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Adult Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Pediatric Pain Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

11. Pain Patch Market, By Adhesive Properties, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hypoallergenic Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Standard Adhesive Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

12. Pain Patch Market, By Duration of Action, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Short-Acting Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Extended-Release Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

13. Pain Patch Market, By Drug Class, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • NSAID Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Local Anesthetic Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Other Medication Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

14. Pain Patch Market, By Distribution Channel, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

15. Pain Patch Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Adhesive Properties, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Duration of Action, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • South Africa
      • Central Africa
      • North Africa

16. Competitive Landscape

  • Hisamitsu Pharmaceutical Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Mylan N.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Endo Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Teikoku Pharma USA, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Acorda Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Ibsa Institut Biochimique SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Alembic Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Noven Pharmaceuticals, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Teva Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Strativa Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Galen Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Napp Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

17. Section

  • Research Methodology
  • About us